Medical Oncology, Moffitt Cancer Center
Dr. Strosberg is a medical oncologist in the Department of Gastrointestinal Oncology, section head of the Neuroendocrine Division and chair of the Gastrointestinal Department Research Program at Moffitt Cancer Center.
He is a professor at the University of South Florida College of Medicine’s Department of Oncologic Sciences. Dr. Strosberg’s clinical interest centers on neuroendocrine malignancies, specifically carcinoid tumors and pancreatic endocrine (islet cell) tumors. His research focus includes the development of novel biomarker-driven therapeutic treatments. Collaborative research has led to the identification of new molecular prognostic markers associated with malignant progression of pancreatic neuroendocrine tumors. His data on the treatment of metastatic pancreatic endocrine tumors with the novel combination of capecitabine and temozolomide was internationally recognized.